{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:10:17Z","timestamp":1787065817698,"version":"build-2736575974"},"reference-count":93,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Recent cohort studies suggest a potential association between atopic dermatitis and dementia, though the evidence remains conflicting. This study aims to elucidate the association between atopic dermatitis and dementia employing systematic review, meta-analysis, and Mendelian randomization (MR). A comprehensive search was performed to select eligible cohort studies using Medline, Embase, Scopus, ScienceDirect, and the Web of Science database. In MR analysis, genomic data from the Genome Wide Association Study (GWAS) (864,982 European individuals) for atopic dermatitis cases and dementia cases were obtained from the MRBase. Statistical analyses included the inverse-variance weighted (IVW) method, sensitivity tests, and MR-PRESSO for outliers. The adjustment accounted for various factors, including sex, age, smoking status, and other medical comorbidities, along with several additional variables. In the systematic review and meta-analysis, 5 longitudinal cohort studies (12,576,235 participants) indicated a significant association between atopic dermatitis and all-cause dementia (adjusted hazard ratio: 1.15, 95% CI: 1.07\u20131.23). Subgroup analyses revealed an adjusted hazard ratio of 1.18 (95% CI: 1.08\u20131.27) for Alzheimer\u2019s disease in patients with atopic dermatitis, and an adjusted hazard ratio of 1.37 (95% CI: 1.21\u20131.55) for all-cause dementia in patients with moderate-to-severe atopic dermatitis. However, MR analysis showed no significant causal link between atopic dermatitis and dementia, Alzheimer\u2019s disease, vascular dementia, or cognitive performance. While the meta-analysis revealed a significant association, MR analysis did not substantiate a significant causal link. Future research should consider demographic variables and medication influences in unravelling the intricate atopic dermatitis\u2013dementia interplay.<\/jats:p>","DOI":"10.2340\/actadv.v105.41321","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:46:44Z","timestamp":1735876004000},"page":"adv41321","source":"Crossref","is-referenced-by-count":9,"title":["Association between Atopic Dermatitis and Dementia: Evidence from Systematic Review, Meta-analysis, and Mendelian Randomization"],"prefix":"10.2340","volume":"105","author":[{"given":"Yeon-Su","family":"Gwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Eon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihyuk","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjeong","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Ryoun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai Sik","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Hak","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"86334","doi-asserted-by":"crossref","unstructured":"Duong S, Patel T, Chang F. Dementia: What pharmacists need to know. Can Pharm J 2017; 150: 118-129","DOI":"10.1177\/1715163517690745"},{"key":"86335","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/1715163517690745","DOI":"10.1177\/1715163517690745"},{"key":"86336","doi-asserted-by":"crossref","unstructured":"Wu Y-T, Clare L, Hindle JV, Nelis SM, Martyr A, Matthews FE. Dementia subtype and living well: results from the Improving the experience of Dementia and Enhancing Active Life (IDEAL) study. BMC Med 2018; 16: 1-9","DOI":"10.1186\/s12916-018-1135-2"},{"key":"86337","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12916-018-1135-2","DOI":"10.1186\/s12916-018-1135-2"},{"key":"86338","unstructured":"World Health Organization. Geneva, Switzerland: World Health Organization. Fact sheets of dementia [Internet]. 2023 [cited 2024 Jun 19]. Available from: https:\/\/ www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"86339","doi-asserted-by":"crossref","unstructured":"Wimo A, Seeher K, Cataldi R, Cyhlarova E, Dielemann JL, Frisell O, et al. The worldwide costs of dementia in 2019. Alzheimers Dement 2023; 10.1002\/alz.12901","DOI":"10.1002\/alz.12901"},{"key":"86340","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/alz.12901","DOI":"10.1002\/alz.12901"},{"key":"86341","doi-asserted-by":"crossref","unstructured":"Cipriani G, Danti S, Picchi L, Nuti A, Fiorino MD. Daily functioning and dementia. Dement Neuropsycho 2020; 14: 93-102","DOI":"10.1590\/1980-57642020dn14-020001"},{"key":"86342","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1590\/1980-57642020dn14-020001","DOI":"10.1590\/1980-57642020dn14-020001"},{"key":"86343","doi-asserted-by":"crossref","unstructured":"Prizer LP, Zimmerman S. Progressive support for activities of daily living for persons living with dementia. Gerontol 2018; 58: S74-S87","DOI":"10.1093\/geront\/gnx103"},{"key":"86344","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/geront\/gnx103","DOI":"10.1093\/geront\/gnx103"},{"key":"86345","doi-asserted-by":"crossref","unstructured":"Brown RT, Diaz-Ramirez LG, Boscardin WJ, Lee SJ, Williams BA, Steinman MA. Association of functional impairment in middle age with hospitalization, nursing home admission, and death. JAMA Intern Med 2019; 179: 668-675","DOI":"10.1001\/jamainternmed.2019.0008"},{"key":"86346","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamainternmed.2019.0008","DOI":"10.1001\/jamainternmed.2019.0008"},{"key":"86347","doi-asserted-by":"crossref","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet 2020; 396: 413-446","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"86348","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"86349","doi-asserted-by":"crossref","unstructured":"Tsakok T, Woolf R, Smith C, Weidinger S, Flohr C. Atopic dermatitis: the skin barrier and beyond. Br J Dermatol 2019; 180: 464-474","DOI":"10.1111\/bjd.16934"},{"key":"86350","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.16934","DOI":"10.1111\/bjd.16934"},{"key":"86351","doi-asserted-by":"crossref","unstructured":"Pan TL, Bai YM, Cheng CM, Tsai SJ, Tsai CF, Su TP, et al. Atopic dermatitis and dementia risk: A nationwide longitudinal study. Ann Allergy Asthma Immunol 2021; 127: 200-205","DOI":"10.1016\/j.anai.2021.03.001"},{"key":"86352","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.anai.2021.03.001","DOI":"10.1016\/j.anai.2021.03.001"},{"key":"86353","doi-asserted-by":"crossref","unstructured":"Magyari A, Ye M, Margolis DJ, McCulloch CE, Cummings SR, Yaffe K, et al. Adult atopic eczema and the risk of dementia: A population-based cohort study. J Am Acad Dermatol 2022; 87: 314-322","DOI":"10.1016\/j.jaad.2022.03.049"},{"key":"86354","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2022.03.049","DOI":"10.1016\/j.jaad.2022.03.049"},{"key":"86355","doi-asserted-by":"crossref","unstructured":"Joh HK, Kwon H, Son KY, Yun JM, Cho SH, Han K, et al. Allergic Diseases and Risk of Incident Dementia and Alzheimer's Disease. Ann Neurol 2023; 93: 384-397","DOI":"10.1002\/ana.26506"},{"key":"86356","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ana.26506","DOI":"10.1002\/ana.26506"},{"key":"86357","doi-asserted-by":"crossref","unstructured":"Yoon S, Kim K, Shin K, Kim HS, Kim B, Kim MB, et al. The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta\u2010analysis of randomized controlled trials. J Eur Acad Dermatol Venereol 2024; 38: 52-61","DOI":"10.1111\/jdv.19426"},{"key":"86358","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.19426","DOI":"10.1111\/jdv.19426"},{"key":"86359","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. [The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaracion PRISMA 2020: una guia actualizada para la publicacion de revisiones sistematicas]. Rev Panam Salud Publica 2022; 46: e112"},{"key":"86360","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.26633\/RPSP.2022.112","DOI":"10.26633\/RPSP.2022.112"},{"key":"86361","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford, 2000."},{"key":"86362","doi-asserted-by":"crossref","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560","DOI":"10.1136\/bmj.327.7414.557"},{"key":"86363","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmj.327.7414.557","DOI":"10.1136\/bmj.327.7414.557"},{"key":"86364","doi-asserted-by":"crossref","unstructured":"Ahn D, Kim J, Kang J, Kim YH, Kim K. Congenital anomalies and maternal age: A systematic review and meta\u2010analysis of observational studies. Acta Obstetric Gynecolog Scand 2022; 101: 484-498","DOI":"10.1111\/aogs.14339"},{"key":"86365","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/aogs.14339","DOI":"10.1111\/aogs.14339"},{"key":"86366","doi-asserted-by":"crossref","unstructured":"Kim CM, Lee S, Hwang W, Son E, Kim TW, Kim K, et al. Obesity and periodontitis: A systematic review and updated meta-analysis. Front Endocrinol (Lausanne) 2022; 13: 999455","DOI":"10.3389\/fendo.2022.999455"},{"key":"86367","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fendo.2022.999455","DOI":"10.3389\/fendo.2022.999455"},{"key":"86368","doi-asserted-by":"crossref","unstructured":"Budu-Aggrey A, Kilanowski A, Sobczyk MK, Shringarpure SS, Mitchell R, Reis K, et al. European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation. Nat Commun 2023; 14: 6172","DOI":"10.1038\/s41467-023-41180-2"},{"key":"86369","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41467-023-41180-2","DOI":"10.1038\/s41467-023-41180-2"},{"key":"86370","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 2018; 7: e34408","DOI":"10.7554\/eLife.34408"},{"key":"86371","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7554\/eLife.34408","DOI":"10.7554\/eLife.34408"},{"key":"86372","doi-asserted-by":"crossref","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50: 693-698","DOI":"10.1038\/s41588-018-0099-7"},{"key":"86373","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41588-018-0099-7","DOI":"10.1038\/s41588-018-0099-7"},{"key":"86374","doi-asserted-by":"crossref","unstructured":"Eriksson UK, Gatz M, Dickman PW, Fratiglioni L, Pedersen NL. Asthma, eczema, rhinitis and the risk for dementia. Dement Geriatr Cogn Disord 2008; 25: 148-156","DOI":"10.1159\/000112729"},{"key":"86375","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000112729","DOI":"10.1159\/000112729"},{"key":"86376","doi-asserted-by":"crossref","unstructured":"Vingeliene S, Hiyoshi A, Carlberg M, Garcia\u2010Argibay M, Lentjes M, Fall K, et al. Atopic dermatitis, systemic inflammation and subsequent dementia risk. JEADV Clin Pract 2023; 10.1002\/jvc2.249","DOI":"10.1002\/jvc2.249"},{"key":"86377","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/jvc2.249","DOI":"10.1002\/jvc2.249"},{"key":"86378","doi-asserted-by":"crossref","unstructured":"Ramirez-Santana M. Limitations and biases in cohort studies. IntechOpen London, UK, 2018.","DOI":"10.5772\/intechopen.74324"},{"key":"86379","doi-asserted-by":"crossref","unstructured":"Lee YH. Overview of Mendelian randomization analysis. Journal of Rheumatic Diseases 2020; 27: 241-246.","DOI":"10.4078\/jrd.2020.27.4.241"},{"key":"86380","doi-asserted-by":"crossref","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munaf\u00f2 MR, et al. Mendelian randomization. Nature Reviews Methods Primers 2022; 2: 6.","DOI":"10.1038\/s43586-021-00092-5"},{"key":"86381","doi-asserted-by":"crossref","unstructured":"Ferretti MT, Cuello AC. Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment? Curr Alzheimer Res 2011; 8: 164-174","DOI":"10.2174\/156720511795255982"},{"key":"86382","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2174\/156720511795255982","DOI":"10.2174\/156720511795255982"},{"key":"86383","doi-asserted-by":"crossref","unstructured":"Griffin WS. Neuroinflammatory cytokine signaling and Alzheimer's disease. N Engl J Med 2013; 368: 770-771","DOI":"10.1056\/NEJMcibr1214546"},{"key":"86384","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMcibr1214546","DOI":"10.1056\/NEJMcibr1214546"},{"key":"86385","doi-asserted-by":"crossref","unstructured":"Meraz-Rios MA, Toral-Rios D, Franco-Bocanegra D, Villeda-Hernandez J, Campos-Pena V. Inflammatory process in Alzheimer's Disease. Front Integr Neurosci 2013; 7: 59","DOI":"10.3389\/fnint.2013.00059"},{"key":"86386","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fnint.2013.00059","DOI":"10.3389\/fnint.2013.00059"},{"key":"86387","doi-asserted-by":"crossref","unstructured":"Xiong Z, Thangavel R, Kempuraj D, Yang E, Zaheer S, Zaheer A. Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain. J Alzheimers Dis 2014; 40: 297-308","DOI":"10.3233\/JAD-132081"},{"key":"86388","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3233\/JAD-132081","DOI":"10.3233\/JAD-132081"},{"key":"86389","doi-asserted-by":"crossref","unstructured":"Abd Rachman Isnadi MF, Chin VK, Abd Majid R, Lee TY, Atmadini Abdullah M, Bello Omenesa R, et al. Critical Roles of IL-33\/ST2 Pathway in Neurological Disorders. Mediators Inflamm 2018; 2018: 5346413","DOI":"10.1155\/2018\/5346413"},{"key":"86390","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1155\/2018\/5346413","DOI":"10.1155\/2018\/5346413"},{"key":"86391","doi-asserted-by":"crossref","unstructured":"Pfab F, Valet M, Napadow V, T\u00f6lle TR, Behrendt H, Ring J, et al. Itch and the brain. Chem Immunol Allergy 2012; 98: 253-265","DOI":"10.1159\/000336529"},{"key":"86392","unstructured":"https:\/\/doi.org\/10.1159\/00033652913"},{"key":"86393","doi-asserted-by":"crossref","unstructured":"Schut C, Mochizuki H, Grossman SK, Lin AC, Conklin CJ, Mohamed FB, et al. Brain Processing of Contagious Itch in Patients with Atopic Dermatitis. Front Psychol 2017; 8: 1267","DOI":"10.3389\/fpsyg.2017.01267"},{"key":"86394","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fpsyg.2017.01267","DOI":"10.3389\/fpsyg.2017.01267"},{"key":"86395","doi-asserted-by":"crossref","unstructured":"Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer's disease. Nat Immunol 2015; 16: 229-236","DOI":"10.1038\/ni.3102"},{"key":"86396","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/ni.3102","DOI":"10.1038\/ni.3102"},{"key":"86397","doi-asserted-by":"crossref","unstructured":"Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol 2018; 18: 759-772","DOI":"10.1038\/s41577-018-0051-1"},{"key":"86398","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41577-018-0051-1","DOI":"10.1038\/s41577-018-0051-1"},{"key":"86399","doi-asserted-by":"crossref","unstructured":"Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 2015; 16: 358-372","DOI":"10.1038\/nrn3880"},{"key":"86400","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/nrn3880","DOI":"10.1038\/nrn3880"},{"key":"86401","doi-asserted-by":"crossref","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol 2015; 14: 388-405","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"86402","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"86403","doi-asserted-by":"crossref","unstructured":"Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 1989; 86: 7611-7615","DOI":"10.1073\/pnas.86.19.7611"},{"key":"86404","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1073\/pnas.86.19.7611","DOI":"10.1073\/pnas.86.19.7611"},{"key":"86405","doi-asserted-by":"crossref","unstructured":"Griffin WST, Barger SW. Neuroinflammatory cytokines - The common thread in Alzheimer pathogenesis. Eur Neurol Rev 2011; 6: 89-96","DOI":"10.17925\/ENR.2011.06.02.89"},{"key":"86406","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.17925\/enr.2011.06.02.89","DOI":"10.17925\/ENR.2011.06.02.89"},{"key":"86407","doi-asserted-by":"crossref","unstructured":"Jones MK, Nair A, Gupta M. Mast cells in neurodegenerative disease. Front Cell Neurosci 2019; 13; 171","DOI":"10.3389\/fncel.2019.00171"},{"key":"86408","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fncel.2019.00171","DOI":"10.3389\/fncel.2019.00171"},{"key":"86409","doi-asserted-by":"crossref","unstructured":"Hendriksen E, van Bergeijk D, Oosting RS, Redegeld FA. Mast cells in neuroinflammation and brain disorders. Neurosci Biobehav Rev 2017; 79: 119-133","DOI":"10.1016\/j.neubiorev.2017.05.001"},{"key":"86410","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.neubiorev.2017.05.001","DOI":"10.1016\/j.neubiorev.2017.05.001"},{"key":"86411","doi-asserted-by":"crossref","unstructured":"Piette F, Belmin J, Vincent H, Schmidt N, Pariel S, Verny M, et al. Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: A randomised, placebo-controlled phase 2 trial. Alzheimers Res Ther 2011; 3: 16","DOI":"10.1186\/alzrt75"},{"key":"86412","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/alzrt75","DOI":"10.1186\/alzrt75"},{"key":"86413","doi-asserted-by":"crossref","unstructured":"Wang L, Gao S, Yu M, Sheng Z, Tan W. Association of asthma with coronary heart disease: A meta analysis of 11 trials. PLoS ONE 2017; 12: e0179335","DOI":"10.1371\/journal.pone.0179335"},{"key":"86414","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1371\/journal.pone.0179335","DOI":"10.1371\/journal.pone.0179335"},{"key":"86415","doi-asserted-by":"crossref","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 2018; 14: 133-150","DOI":"10.1038\/nrneurol.2017.188"},{"key":"86416","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/nrneurol.2017.188","DOI":"10.1038\/nrneurol.2017.188"},{"key":"86417","doi-asserted-by":"crossref","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer's disease. Lancet 2021; 397: 1577-1590","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"86418","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"86419","doi-asserted-by":"crossref","unstructured":"Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study. JAMA Intern Med 2015; 175: 401-407","DOI":"10.1001\/jamainternmed.2014.7663"},{"key":"86420","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamainternmed.2014.7663","DOI":"10.1001\/jamainternmed.2014.7663"},{"key":"86421","doi-asserted-by":"crossref","unstructured":"Wacholder S, Hartge P, Lubin JH, Dosemeci M. Non-differential misclassification and bias towards the null: a clarification. Occup Environ Med 1995; 52: 557-558","DOI":"10.1136\/oem.52.8.557"},{"key":"86422","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/oem.52.8.557","DOI":"10.1136\/oem.52.8.557"},{"key":"86423","doi-asserted-by":"crossref","unstructured":"Metelli S, Chaimani A. Challenges in meta-analyses with observational studies. BMJ Ment Health 2020; 23: 83-87.","DOI":"10.1136\/ebmental-2019-300129"},{"key":"86424","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/ebmental-2019-300129","DOI":"10.1136\/ebmental-2019-300129"},{"key":"86425","doi-asserted-by":"crossref","unstructured":"Clayton GL, Gon\u00e7alves A, Goulding N, Borges MC, Holmes MV, Davey G, et al. A framework for assessing selection and misclassification bias in mendelian randomisation studies: an illustrative example between body mass index and covid-19. BMJ 2023; 381: e072148.","DOI":"10.1136\/bmj-2022-072148"},{"key":"86426","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmj-2022-072148","DOI":"10.1136\/bmj-2022-072148"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/41321\/48535","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/41321\/48535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:47:39Z","timestamp":1735876059000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/41321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":93,"URL":"https:\/\/doi.org\/10.2340\/actadv.v105.41321","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,3]]}}}